The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025. There are two other vaccines ...
With the possibility of Robert F. Kennedy, Jr. being involved in health policy in the next administration, vaccination – ...
They found that mRNA vaccines that target C. diff cells and the toxins they produce generated a lasting immune response in ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
Hosted on MSN8h
Moderna’s mRESVIA vaccine gains Health Canada approvalModerna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...
Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
HONG KONG SAR - Media OutReach Newswire - 30 October 2024 - AIM Vaccine (06660.HK), the leader in Chinese mRNA vaccines, announced on 30th October that mRNA respiratory ...
The top-line beat was led by its higher than anticipated sales of Covid-19 vaccine, while its recently approved respiratory syncytial virus vaccine raked in just $10 ...
Policy, funding, and public apathy hold back the search for more advanced COVID vaccines — but researchers persist and have ...
Southwest District Health ended its COVID-19 vaccination program. Others in Texas, Florida and Michigan also pushed back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback